CN Stock MarketDetailed Quotes

603235 JiangXi Tianxin Pharmaceutical

Watchlist
  • 26.24
  • -0.02-0.08%
Market Closed Sep 13 15:00 CST
11.49BMarket Cap23.39P/E (TTM)

JiangXi Tianxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
-15.02%1.49B
-9.73%1.12B
-4.61%578.12M
-8.63%2.3B
-0.48%1.75B
-2.05%1.24B
-5.43%606.09M
Operating revenue
-4.81%1.07B
-14.46%494.5M
-18.34%1.88B
-15.02%1.49B
-9.73%1.12B
-4.61%578.12M
-8.63%2.3B
-0.48%1.75B
-2.05%1.24B
-5.43%606.09M
Other operating revenue
-20.90%14.41M
----
-40.82%30.6M
----
-33.57%18.22M
----
-7.61%51.71M
----
95.18%27.43M
----
Total operating cost
-9.95%671.17M
-27.47%329.54M
-17.19%1.36B
-9.82%1.04B
-7.65%745.33M
9.86%454.33M
-2.79%1.64B
-0.37%1.16B
-0.11%807.08M
0.76%413.55M
Operating cost
-12.49%618M
-25.16%296.34M
-19.71%1.16B
-10.78%941.71M
-2.58%706.2M
11.93%395.95M
1.07%1.45B
7.12%1.06B
5.30%724.9M
-2.01%353.75M
Operating tax surcharges
3.48%10.07M
25.85%5.14M
-9.84%19.81M
-3.37%15.28M
-5.49%9.73M
28.86%4.09M
-3.53%21.97M
-6.32%15.81M
-15.95%10.29M
-43.56%3.17M
Operating expense
7.59%17.04M
-44.25%3.09M
7.05%32.86M
5.58%22.74M
15.56%15.84M
12.46%5.54M
10.03%30.7M
-2.33%21.53M
2.36%13.71M
-10.49%4.93M
Administration expense
-8.27%58.41M
-14.01%27.93M
-5.43%136.35M
1.25%103.94M
-0.78%63.68M
3.64%32.48M
28.40%144.18M
31.81%102.66M
25.29%64.18M
21.73%31.35M
Financial expense
12.58%-77.41M
-12,866.80%-25.73M
-13.09%-102.43M
-3.88%-102.37M
-105.44%-88.55M
-95.80%201.56K
-349.82%-90.57M
-647.90%-98.54M
-335.52%-43.1M
12,971.57%4.8M
-Interest expense (Financial expense)
299.85%2.06M
----
-69.69%2.1M
----
-90.30%515.38K
----
-45.32%6.93M
----
-15.67%5.31M
17.07%3.05M
-Interest Income (Financial expense)
-33.63%-44.31M
-99.07%-24.23M
-358.17%-74.46M
----
-4,465.15%-33.15M
-4,403.46%-12.17M
-274.53%-16.25M
----
79.53%-726.25K
87.40%-270.22K
Research and development
17.25%45.05M
41.75%22.77M
25.15%111.96M
3.25%62.67M
3.58%38.42M
3.26%16.07M
51.79%89.46M
45.11%60.7M
52.20%37.09M
24.15%15.56M
Credit Impairment Loss
-227.63%-2.64M
-344.43%-2.36M
-2.30%3.16M
140.26%6.42M
223.15%2.07M
56.22%-530.47K
145.98%3.23M
-28.59%2.67M
59.86%-1.68M
56.85%-1.21M
Asset Impairment Loss
-472.13%-5.23M
----
-197.36%-12.36M
5.47%-914.33K
5.47%-914.33K
----
-644.32%-4.16M
79.89%-967.27K
-110.08%-967.27K
---344.85K
Other net revenue
2.25%16.45M
64.24%11.41M
-36.20%40.49M
-18.46%47.55M
-62.35%16.09M
-61.94%6.95M
44.36%63.47M
11.19%58.32M
20.69%42.74M
66.79%18.25M
Fair value change income
----
----
----
----
----
----
200.00%4.33M
--4.33M
--4.33M
----
Invest income
-69.06%364.87K
6.51%364.87K
-68.72%2.07M
-46.47%1.49M
137.68%1.18M
-89.26%342.57K
391.22%6.63M
-11.65%2.79M
-83.53%496.16K
585.20%3.19M
-Including: Investment income associates
----
----
-299.01%-379.69K
----
----
---269.56K
---95.16K
----
----
----
Other revenue
74.21%23.96M
87.85%13.4M
-10.87%47.62M
-18.07%40.55M
-66.09%13.75M
-57.07%7.14M
-8.14%53.43M
-1.72%49.5M
9.48%40.56M
25.09%16.62M
Operating profit
5.26%411.9M
34.91%176.37M
-22.53%562.22M
-24.59%490.92M
-17.96%391.31M
-37.98%130.73M
-17.23%725.7M
0.26%651M
-3.60%476.97M
-12.67%210.79M
Add:Non operating Income
4,280.65%31.99K
--14.02K
89.98%6.05M
-89.49%10.27K
-90.45%730.16
----
160.11%3.18M
873.64%97.76K
1.21%7.65K
106.38%6.64K
Less:Non operating expense
296.38%1.87M
705.13%644.1K
-0.82%3.09M
-36.01%1.72M
-74.34%470.78K
-89.09%80K
-32.57%3.12M
71.49%2.69M
206.93%1.83M
31.46%733.25K
Total profit
4.92%410.06M
34.51%175.74M
-22.13%565.17M
-24.55%489.21M
-17.74%390.84M
-37.80%130.65M
-16.90%725.76M
0.10%648.4M
-3.85%475.14M
-12.77%210.07M
Less:Income tax cost
6.59%64.9M
27.82%28.19M
-13.82%89.32M
-21.51%76.31M
-17.60%60.88M
-30.90%22.05M
-19.96%103.64M
-3.88%97.22M
-0.76%73.89M
-8.95%31.92M
Net profit
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
-13.42%178.15M
Net profit from continuing operation
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
-13.42%178.15M
Net profit of parent company owners
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
-13.42%178.15M
Earning per share
Basic earning per share
5.33%0.79
36.00%0.34
-27.81%1.09
-31.39%0.94
-26.47%0.75
-44.44%0.25
-20.11%1.51
-1.44%1.37
-4.67%1.02
-13.46%0.45
Diluted earning per share
5.33%0.79
36.00%0.34
-27.81%1.09
-31.39%0.94
-26.47%0.75
-44.44%0.25
-20.11%1.51
-1.44%1.37
-4.67%1.02
-13.46%0.45
Other composite income
Total composite income
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
-13.42%178.15M
Total composite income of parent company owners
4.61%345.17M
35.87%147.55M
-23.51%475.85M
-25.09%412.9M
-17.77%329.96M
-39.04%108.6M
-16.37%622.12M
0.84%551.18M
-4.40%401.25M
-13.42%178.15M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -4.81%1.07B-14.46%494.5M-18.34%1.88B-15.02%1.49B-9.73%1.12B-4.61%578.12M-8.63%2.3B-0.48%1.75B-2.05%1.24B-5.43%606.09M
Operating revenue -4.81%1.07B-14.46%494.5M-18.34%1.88B-15.02%1.49B-9.73%1.12B-4.61%578.12M-8.63%2.3B-0.48%1.75B-2.05%1.24B-5.43%606.09M
Other operating revenue -20.90%14.41M-----40.82%30.6M-----33.57%18.22M-----7.61%51.71M----95.18%27.43M----
Total operating cost -9.95%671.17M-27.47%329.54M-17.19%1.36B-9.82%1.04B-7.65%745.33M9.86%454.33M-2.79%1.64B-0.37%1.16B-0.11%807.08M0.76%413.55M
Operating cost -12.49%618M-25.16%296.34M-19.71%1.16B-10.78%941.71M-2.58%706.2M11.93%395.95M1.07%1.45B7.12%1.06B5.30%724.9M-2.01%353.75M
Operating tax surcharges 3.48%10.07M25.85%5.14M-9.84%19.81M-3.37%15.28M-5.49%9.73M28.86%4.09M-3.53%21.97M-6.32%15.81M-15.95%10.29M-43.56%3.17M
Operating expense 7.59%17.04M-44.25%3.09M7.05%32.86M5.58%22.74M15.56%15.84M12.46%5.54M10.03%30.7M-2.33%21.53M2.36%13.71M-10.49%4.93M
Administration expense -8.27%58.41M-14.01%27.93M-5.43%136.35M1.25%103.94M-0.78%63.68M3.64%32.48M28.40%144.18M31.81%102.66M25.29%64.18M21.73%31.35M
Financial expense 12.58%-77.41M-12,866.80%-25.73M-13.09%-102.43M-3.88%-102.37M-105.44%-88.55M-95.80%201.56K-349.82%-90.57M-647.90%-98.54M-335.52%-43.1M12,971.57%4.8M
-Interest expense (Financial expense) 299.85%2.06M-----69.69%2.1M-----90.30%515.38K-----45.32%6.93M-----15.67%5.31M17.07%3.05M
-Interest Income (Financial expense) -33.63%-44.31M-99.07%-24.23M-358.17%-74.46M-----4,465.15%-33.15M-4,403.46%-12.17M-274.53%-16.25M----79.53%-726.25K87.40%-270.22K
Research and development 17.25%45.05M41.75%22.77M25.15%111.96M3.25%62.67M3.58%38.42M3.26%16.07M51.79%89.46M45.11%60.7M52.20%37.09M24.15%15.56M
Credit Impairment Loss -227.63%-2.64M-344.43%-2.36M-2.30%3.16M140.26%6.42M223.15%2.07M56.22%-530.47K145.98%3.23M-28.59%2.67M59.86%-1.68M56.85%-1.21M
Asset Impairment Loss -472.13%-5.23M-----197.36%-12.36M5.47%-914.33K5.47%-914.33K-----644.32%-4.16M79.89%-967.27K-110.08%-967.27K---344.85K
Other net revenue 2.25%16.45M64.24%11.41M-36.20%40.49M-18.46%47.55M-62.35%16.09M-61.94%6.95M44.36%63.47M11.19%58.32M20.69%42.74M66.79%18.25M
Fair value change income ------------------------200.00%4.33M--4.33M--4.33M----
Invest income -69.06%364.87K6.51%364.87K-68.72%2.07M-46.47%1.49M137.68%1.18M-89.26%342.57K391.22%6.63M-11.65%2.79M-83.53%496.16K585.20%3.19M
-Including: Investment income associates ---------299.01%-379.69K-----------269.56K---95.16K------------
Other revenue 74.21%23.96M87.85%13.4M-10.87%47.62M-18.07%40.55M-66.09%13.75M-57.07%7.14M-8.14%53.43M-1.72%49.5M9.48%40.56M25.09%16.62M
Operating profit 5.26%411.9M34.91%176.37M-22.53%562.22M-24.59%490.92M-17.96%391.31M-37.98%130.73M-17.23%725.7M0.26%651M-3.60%476.97M-12.67%210.79M
Add:Non operating Income 4,280.65%31.99K--14.02K89.98%6.05M-89.49%10.27K-90.45%730.16----160.11%3.18M873.64%97.76K1.21%7.65K106.38%6.64K
Less:Non operating expense 296.38%1.87M705.13%644.1K-0.82%3.09M-36.01%1.72M-74.34%470.78K-89.09%80K-32.57%3.12M71.49%2.69M206.93%1.83M31.46%733.25K
Total profit 4.92%410.06M34.51%175.74M-22.13%565.17M-24.55%489.21M-17.74%390.84M-37.80%130.65M-16.90%725.76M0.10%648.4M-3.85%475.14M-12.77%210.07M
Less:Income tax cost 6.59%64.9M27.82%28.19M-13.82%89.32M-21.51%76.31M-17.60%60.88M-30.90%22.05M-19.96%103.64M-3.88%97.22M-0.76%73.89M-8.95%31.92M
Net profit 4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M-13.42%178.15M
Net profit from continuing operation 4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M-13.42%178.15M
Net profit of parent company owners 4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M-13.42%178.15M
Earning per share
Basic earning per share 5.33%0.7936.00%0.34-27.81%1.09-31.39%0.94-26.47%0.75-44.44%0.25-20.11%1.51-1.44%1.37-4.67%1.02-13.46%0.45
Diluted earning per share 5.33%0.7936.00%0.34-27.81%1.09-31.39%0.94-26.47%0.75-44.44%0.25-20.11%1.51-1.44%1.37-4.67%1.02-13.46%0.45
Other composite income
Total composite income 4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M-13.42%178.15M
Total composite income of parent company owners 4.61%345.17M35.87%147.55M-23.51%475.85M-25.09%412.9M-17.77%329.96M-39.04%108.6M-16.37%622.12M0.84%551.18M-4.40%401.25M-13.42%178.15M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data